Charles D Scales1, Christopher S Saigal2, Janet M Hanley3, Andrew W Dick3, Claude M Setodji3, Mark S Litwin4. 1. Robert Wood Johnson Foundation Clinical Scholars Program and US Department of Veterans Affairs; Department of Urology, University of California, Los Angeles, CA; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA. Electronic address: chuck.scales@duke.edu. 2. Department of Urology, University of California, Los Angeles, CA. 3. RAND Corporation, Santa Monica, CA. 4. Department of Urology, University of California, Los Angeles, CA; RAND Corporation, Santa Monica, CA; Department of Health Policy & Management, Fielding School of Public Health, University of California, Los Angeles, CA.
Abstract
BACKGROUND: Unplanned follow-up care is the focus of intense health policy interest, as evidenced by recent financial penalties imposed under the Affordable Care Act. To date, however, unplanned postoperative care remains poorly characterized, particularly for patients with kidney stones. Our objective was to describe the frequency, variation, and financial impact of unplanned, high-acuity, follow-up visits in the treatment of patients with urinary stone disease. METHODS: We identified privately insured patients undergoing percutaneous nephrostolithotomy, ureteroscopy, or shock-wave lithotripsy for stone disease. The primary outcome was occurrence of an emergency department visit or hospital admission within 30 days of the procedure. Multivariable models estimated the odds of an unplanned visit and the incremental cost of those visits, controlling for important covariates. RESULTS: We identified 93,523 initial procedures to fragment or remove stones. Overall, 1 in 7 patients had an unplanned postprocedural visit. Unplanned visits were least common after shock-wave lithotripsy (12%) and occurred with similar frequency after ureteroscopy and percutaneous nephrostolithotomy (15%). Procedures at high-volume facilities were substantially less likely to result in an unplanned visit (odds ratio 0.80, 95% confidence interval [95% CI] 0.74-0.87, P < .001). When an unplanned visit occurred, adjusted incremental expenditures per episode were greater after shock-wave lithotripsy ($32,156 [95% CI $30,453-33,859]) than after ureteroscopy ($23,436 [95% CI $22,281-24,590]). CONCLUSION: Patients not infrequently experience an unplanned, high-acuity visit after low-risk procedures to remove urinary stones, and the cost of these encounters is substantial. Interventions are indicated to identify and reduce preventable unplanned visits.
BACKGROUND: Unplanned follow-up care is the focus of intense health policy interest, as evidenced by recent financial penalties imposed under the Affordable Care Act. To date, however, unplanned postoperative care remains poorly characterized, particularly for patients with kidney stones. Our objective was to describe the frequency, variation, and financial impact of unplanned, high-acuity, follow-up visits in the treatment of patients with urinary stone disease. METHODS: We identified privately insured patients undergoing percutaneous nephrostolithotomy, ureteroscopy, or shock-wave lithotripsy for stone disease. The primary outcome was occurrence of an emergency department visit or hospital admission within 30 days of the procedure. Multivariable models estimated the odds of an unplanned visit and the incremental cost of those visits, controlling for important covariates. RESULTS: We identified 93,523 initial procedures to fragment or remove stones. Overall, 1 in 7 patients had an unplanned postprocedural visit. Unplanned visits were least common after shock-wave lithotripsy (12%) and occurred with similar frequency after ureteroscopy and percutaneous nephrostolithotomy (15%). Procedures at high-volume facilities were substantially less likely to result in an unplanned visit (odds ratio 0.80, 95% confidence interval [95% CI] 0.74-0.87, P < .001). When an unplanned visit occurred, adjusted incremental expenditures per episode were greater after shock-wave lithotripsy ($32,156 [95% CI $30,453-33,859]) than after ureteroscopy ($23,436 [95% CI $22,281-24,590]). CONCLUSION:Patients not infrequently experience an unplanned, high-acuity visit after low-risk procedures to remove urinary stones, and the cost of these encounters is substantial. Interventions are indicated to identify and reduce preventable unplanned visits.
Authors: Glenn M Preminger; Hans-Göran Tiselius; Dean G Assimos; Peter Alken; Colin Buck; Michele Gallucci; Thomas Knoll; James E Lingeman; Stephen Y Nakada; Margaret Sue Pearle; Kemal Sarica; Christian Türk; J Stuart Wolf Journal: J Urol Date: 2007-12 Impact factor: 7.450
Authors: Brent K Hollenbeck; Stephanie Daignault; Rodney L Dunn; Scott Gilbert; Alon Z Weizer; David C Miller Journal: J Urol Date: 2007-06 Impact factor: 7.450
Authors: Wendy Siu; Stephanie Daignault; David C Miller; Rodney L Dunn; Scott Gilbert; Alon Z Weizer; Zaojun Ye; Brent K Hollenbeck Journal: Urol Oncol Date: 2007-12-21 Impact factor: 3.498
Authors: Elena Birman-Deych; Amy D Waterman; Yan Yan; David S Nilasena; Martha J Radford; Brian F Gage Journal: Med Care Date: 2005-05 Impact factor: 2.983
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Steffen Lebentrau; Thomas Enzmann; Mike Lehsnau; Frank Christoph; Martin Schostak; Matthias May Journal: World J Urol Date: 2018-08-09 Impact factor: 4.226
Authors: Maxim Avanesov; Julja Togmat; Mehtap Solmaz; Michael Gerhard Kaul; Azien Laqmani; Helena Guerreiro; Sarah Keller; Lars Weisbach; Gerhard Adam; Jin Yamamura Journal: Eur Radiol Date: 2019-06-17 Impact factor: 5.315
Authors: Ibrahim Buldu; Abdulkadir Tepeler; Tuna Karatag; Ekrem Ozyuvali; Fatih Elbir; Mustafa Yordam; Ali Unsal Journal: World J Urol Date: 2015-12-22 Impact factor: 4.226
Authors: Charles D Scales; Gregory E Tasian; Andrew L Schwaderer; David S Goldfarb; Robert A Star; Ziya Kirkali Journal: Clin J Am Soc Nephrol Date: 2016-03-10 Impact factor: 8.237
Authors: Ahmed R El-Nahas; Diaa-Eldin Taha; Mohamed M Elsaadany; Mohamed H Zahran; Mohamed Hassan; Khaled Z Sheir Journal: Urolithiasis Date: 2017-05-29 Impact factor: 3.436
Authors: Tae Jin Kim; In Jae Lee; Jung Keun Lee; Hak Min Lee; Chang Wook Jeong; Sung Kyu Hong; Seok-Soo Byun; Jong Jin Oh Journal: World J Urol Date: 2018-10-03 Impact factor: 4.226